Andorra vs Eastern Europe: Proportion of the target population who received a 3rd dose of
Andorra
96.0%
in 2024
Eastern Europe
78.0%
in 2024
Andorra rank
16th
Eastern Europe rank
15th
Proportion of the target population who received a 3rd dose of over time
- Andorra
- Eastern Europe
How they compare
Andorra currently reports 96.0% against 78.0% in Eastern Europe, a difference of 18.0%.
That makes Andorra's figure about 1.2 times Eastern Europe's.
Across all 11 years both countries report, Andorra has been ahead every year.
Andorra ranks 16th and Eastern Europe ranks 15th of 157 countries.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Eastern Europe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.2% | 35.3% | 58.8% | Andorra |
| 2020s | 95.2% | 74.8% | 20.4% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Andorra or Eastern Europe?
- Andorra, at 96.0% against 78.0% in Eastern Europe as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Andorra and Eastern Europe?
- 18.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Eastern Europe?
- 11 years are reported by both, from 2014 to 2024.
- How do Andorra and Eastern Europe rank globally for proportion of the target population who received a 3rd dose of?
- Andorra ranks 16th and Eastern Europe ranks 15th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.